1340 related articles for article (PubMed ID: 30285771)
1. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
2. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
4. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
5. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
6. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
[TBL] [Abstract][Full Text] [Related]
7. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
8. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y
Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
11. [Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].
Yu G; Ou ZY; Tao QY; Wan GY; Lu ZH; Lang B
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1494-1500. PubMed ID: 29180330
[TBL] [Abstract][Full Text] [Related]
12. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
13. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS
Cells; 2020 Jun; 9(6):. PubMed ID: 32517366
[TBL] [Abstract][Full Text] [Related]
14. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
Chen C; Shang A; Sun Z; Gao Y; Huang J; Ping Y; Chang W; Gu C; Sun J; Ji P; Yuan Y; Lu R; Li D
J Immunol Res; 2022; 2022():9038808. PubMed ID: 35127956
[TBL] [Abstract][Full Text] [Related]
15. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
Li RK; Gao J; Guo LH; Huang GQ; Luo WH
Cancer Gene Ther; 2017 Jul; 24(7):309-315. PubMed ID: 28731027
[TBL] [Abstract][Full Text] [Related]
16. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Qiu T; Xue M; Li X; Li F; Liu S; Yao C; Chen W
Mol Omics; 2022 Dec; 18(10):938-947. PubMed ID: 36164958
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.
Zhang R; Guo Y; Ma Z; Ma G; Xue Q; Li F; Liu L
Oncotarget; 2017 Apr; 8(16):26079-26089. PubMed ID: 28212532
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Long Noncoding RNA PTENP1 Inhibits Cell Proliferation and Migration via Suppression of miR-19b in Breast Cancer Cells.
Shi X; Tang X; Su L
Oncol Res; 2018 Jul; 26(6):869-878. PubMed ID: 29212574
[TBL] [Abstract][Full Text] [Related]
20. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
